{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:17:20Z","timestamp":1794565040915,"version":"4.9.1"},"reference-count":160,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["EY01792"],"award-info":[{"award-number":["EY01792"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"CDMRP","doi-asserted-by":"publisher","award":["VR170180"],"award-info":[{"award-number":["VR170180"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.survophthal.2023.02.006","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T11:29:42Z","timestamp":1677756582000},"page":"697-712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Ocular graft-versus-host disease (oGVHD): From A to Z"],"prefix":"10.1016","volume":"68","author":[{"given":"Mohammad","family":"Soleimani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pouya","family":"Mahdavi Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasra","family":"Cheraqpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghuram","family":"Koganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Masoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mahbod","family":"Baharnoori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirataollah","family":"Salabati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali R.","family":"Djalilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.survophthal.2023.02.006_bib0001","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.ophtha.2016.02.044","article-title":"A clinical trial comparing the safety and efficacy of topical tacrolimus versus methylprednisolone in ocular graft-versus-host disease","volume":"123","author":"Abud","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0002","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jtos.2020.05.012","article-title":"Correlation of corneal immune cell changes with clinical severity in dry eye disease: An in vivo confocal microscopy study","volume":"19","author":"Aggarwal","year":"2021","journal-title":"Ocular Surface"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0003","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jamaophthalmol.2013.195","article-title":"Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial","volume":"131","author":"Amparo","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0004","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jtos.2019.03.010","article-title":"Neutrophil extracellular traps (NETs) contribute to pathological changes of ocular graft-vs.-host disease (oGVHD) dry eye: implications for novel biomarkers and therapeutic strategies","volume":"17","author":"An","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ajo.2016.12.026","article-title":"Elevated neutrophil elastase in tears of ocular graft-versus-host disease patients","volume":"176","author":"Arafat","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0006","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbmt.2014.10.021","article-title":"Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research","volume":"21","author":"Arai","year":"2015","journal-title":"Biol Blood Marrow Transplantation"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0007","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/112067210601600104","article-title":"Upregulation of ICAM-1 expression in the conjunctiva of patients with chronic graft-versus-host disease","volume":"16","author":"Aronni","year":"2006","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0008","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/112067210601600104","article-title":"Upregulation of ICAM-1 expression in the conjunctiva of patients with chronic graft-versus-host disease","volume":"16","author":"Aronni","year":"2006","journal-title":"Eur J Ophthal"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0009","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1542-0124(12)70207-0","article-title":"Chronic ocular surface disease after allogeneic bone marrow transplantation","volume":"3","author":"Balaram","year":"2005","journal-title":"Ocular Surface"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0010","first-page":"2533","article-title":"Morphologic evaluation of meibomian glands in chronic graft-versus-host disease using in vivo laser confocal microscopy","volume":"17","author":"Ban","year":"2011","journal-title":"Mol Vision"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0011","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jtos.2018.04.001","article-title":"Ocular chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in an Italian referral center","volume":"16","author":"Berchicci","year":"2018","journal-title":"Ocul Surf"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0012","doi-asserted-by":"crossref","first-page":"8269","DOI":"10.1126\/scitranslmed.aai8269","article-title":"Targeting aurora kinase A and JAK2 prevents GVHD while maintaining Treg and antitumor CTL function","volume":"9","author":"Betts","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0013","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/jamaophthalmol.2017.3204","article-title":"Conjunctival and limbal transplantation from the same living-related bone marrow donor to patients with severe ocular graft-vs-host disease","volume":"135","author":"Busin","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0014","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.bbmt.2015.03.024","article-title":"National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. The 2014 ancillary therapy and supportive care working group report","volume":"21","author":"Carpenter","year":"2015","journal-title":"Biol Blood Marrow Transplantation"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0015","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1080\/10428194.2019.1695049","article-title":"Lifitegrast ophthalmic solution for treatment of ocular chronic graft-versus-host disease","volume":"61","author":"Chhabra","year":"2020","journal-title":"Leukemia lymphoma"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0016","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.ophtha.2017.05.031","article-title":"Meibomian gland disease: the role of gland dysfunction in dry eye disease","volume":"124","author":"Chhadva","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0017","first-page":"393","article-title":"Comparison of the meibomian gland dysfunction in patients with chronic ocular graft-versus-host disease and Sj\u00f6gren's syndrome","volume":"12","author":"Choi","year":"2019","journal-title":"Int J Ophthal"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0018","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.1167\/iovs.15-16736","article-title":"Gene expression-based predictive models of graft versus host disease-associated dry eye","volume":"56","author":"Cocho","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0019","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1167\/iovs.15-18615","article-title":"Biomarkers in ocular chronic graft versus host disease: tear cytokine- and chemokine-based predictive model","volume":"57","author":"Cocho","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120284","article-title":"Immunomodulatory cross-talk between conjunctival goblet cells and dendritic cells","volume":"10","author":"Contreras-Ruiz","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0021","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2141.2005.05616.x","article-title":"Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease","volume":"130","author":"Couriel","year":"2005","journal-title":"British journal of haematology"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0022","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1542-0124(11)70022-2","article-title":"Tear lipocalin: structure and function","volume":"9","author":"Dartt","year":"2011","journal-title":"Ocul Surf"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0023","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12014-020-09307-5","article-title":"Tear proteomic profile in three distinct ocular surface diseases: keratoconus, pterygium, and dry eye related to graft-versus-host disease","volume":"17","author":"de Almeida Borges","year":"2020","journal-title":"Clin Proteomics"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0024","series-title":"Dry eye disease in chronic graft-versus-host disease: results from a Spanish retrospective cohort study: Transplantation proceedings","first-page":"1934","volume":"43","author":"De la Parra-Col\u00edn","year":"2011"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1590\/S0004-27492008000700017","article-title":"Rationale for anti-inflammatory therapy in dry eye syndrome","volume":"71","author":"De Paiva","year":"2008","journal-title":"Arquivos Brasileiros de Oftalmologia"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0026","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/gb-2006-7-8-r72","article-title":"Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors","volume":"7","author":"de Souza","year":"2006","journal-title":"Genome Biol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0027","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/ICO.0b013e318226bf97","article-title":"Diagnosis and treatment of ocular chronic graft-versus-host disease: Report from the German\u2013Austrian\u2013Swiss Consensus Conference on Clinical Practice in Chronic GVHD","volume":"31","author":"Dietrich-Ntoukas","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0028","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/ICO.0b013e318226bf97","article-title":"Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss consensus conference on clinical practice in chronic GVHD","volume":"31","author":"Dietrich-Ntoukas","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0029","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/156652413804486214","article-title":"Functions of S100 proteins","volume":"13","author":"Donato","year":"2013","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0030","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/bmt.2015.72","article-title":"Meibography and meibomian gland measurements in ocular graft-versus-host disease","volume":"50","author":"Engel","year":"2015","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0031","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41409-017-0068-2","article-title":"Ruxolitinib in steroid-refractory chronic graft-versus-host disease: experience of a single center","volume":"53","author":"Ferreira","year":"2018","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0032","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/ijms22010116","article-title":"Therapeutic potential of the molecular chaperone and matrix metalloproteinase inhibitor clusterin for dry eye","volume":"22","author":"Fini","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0033","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.biochi.2008.07.007","article-title":"Role of lactoferrin in the tear film","volume":"91","author":"Flanagan","year":"2009","journal-title":"Biochimie"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0034","first-page":"606","article-title":"How we treat chronic graft-versus-host disease. Blood","volume":"125","author":"Flowers","year":"2015","journal-title":"J Am Soc Hematol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0035","first-page":"3988","article-title":"Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans. Blood","volume":"123","author":"Flynn","year":"2014","journal-title":"J Am Soc Hematol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0036","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1136\/bjophthalmol-2014-305425","article-title":"Inhibition by rebamipide of cytokine-induced or lipopolysaccharide-induced chemokine synthesis in human corneal fibroblasts","volume":"98","author":"Fukuda","year":"2014","journal-title":"Br J Ophthal"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0037","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000131091","article-title":"Surgical occlusion of the lacrimal drainage system","volume":"41","author":"Geerling","year":"2008","journal-title":"Dev Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0038","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1167\/iovs.18-24433","article-title":"Tear film proteomics reveal important differences between patients with and without ocular GvHD after allogeneic hematopoietic cell transplantation","volume":"59","author":"Gerber-Hollbach","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0039","first-page":"79","article-title":"Pathophysiology of GvHD and other HSCT-related major complications","volume":"8","author":"Ghimire","year":"2017","journal-title":"Fron Immunol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0040","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fimmu.2017.00079","article-title":"Pathophysiology of GvHD and Other HSCT-related major complications","volume":"8","author":"Ghimire","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0041","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41433-018-0210-4","article-title":"Comparison among different diagnostic criteria for chronic ocular graft-versus-host disease applied with and without pre-transplant ophthalmological examination","volume":"33","author":"Giannaccare","year":"2019","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0042","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/ehm.10.21","article-title":"Allogeneic hematopoietic cell transplantation: the state of the art","volume":"3","author":"Gyurkocza","year":"2010","journal-title":"Expert Rev hematol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0043","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1242\/jcs.087288","article-title":"Lamins at a glance","volume":"125","author":"Ho","year":"2012","journal-title":"J Cell Sci"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0044","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.exer.2013.07.027","article-title":"Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins","volume":"117","author":"Hodges","year":"2013","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0045","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jamaophthalmol.2021.3943","article-title":"Efficacy of lifitegrast ophthalmic solution, 5.0%, in patients with moderate to severe dry eye disease: a post hoc analysis of 2 randomized clinical trials","volume":"139","author":"Holland","year":"2021","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0046","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jtos.2019.12.005","article-title":"Tear cytokine levels in the diagnosis and severity assessment of ocular chronic graft-versus-host disease(GVHD)","volume":"18","author":"Hu","year":"2020","journal-title":"Ocul Surf"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0047","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.yexcr.2007.08.004","article-title":"Accelerated telomere shortening and replicative senescence in human fibroblasts overexpressing mutant and wild-type lamin A","volume":"314","author":"Huang","year":"2008","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12886-021-01925-3","article-title":"Two case reports of continued progression of chronic ocular graft-versus-host disease without concurrent systemic comorbidities treated by amniotic membrane transplantation","volume":"21","author":"Ikarashi","year":"2021","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0049","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.bbmt.2012.05.016","article-title":"Clinical benefit of response in chronic graft-versus-host disease","volume":"18","author":"Inamoto","year":"2012","journal-title":"Biol Blood Marrow Transplantation"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0050","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1097\/ICO.0b013e318276bc56","article-title":"Prevalence of dry eye syndrome after allogeneic hematopoietic stem cell transplantation","volume":"32","author":"Ivanir","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0051","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archopht.1983.01040010585011","article-title":"The eye in bone marrow transplantation","volume":"101","author":"Jabs","year":"1983","journal-title":"II. Histopathol. Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0052","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/bmt.2012.56","article-title":"Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria","volume":"47","author":"Jacobs","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0053","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplantation"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0054","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41409-020-0993-3","article-title":"Chronic ocular graft-versus-host disease after allogeneic haematopoietic stem cell transplantation in Denmark\u2013factors associated with risks and rates in adults according to conditioning regimen","volume":"56","author":"Jeppesen","year":"2021","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0055","first-page":"2249","article-title":"Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice. Blood","volume":"127","author":"Jin","year":"2016","journal-title":"J Am Soc Hematol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0056","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231473","article-title":"Aberrant HLA-DR expression in the conjunctival epithelium after autologous serum treatment in patients with graft-versus-host disease or Sj\u00f6gren's syndrome","volume":"15","author":"Jirsova","year":"2020","journal-title":"PloS one"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0057","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1046\/j.1365-3083.2000.00790.x","article-title":"Role of J chain in secretory immunoglobulin formation","volume":"52","author":"Johansen","year":"2000","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0058","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/mi.2011.37","article-title":"Regulation of the polymeric immunoglobulin receptor and IgA transport: new advances in environmental factors that stimulate pIgR expression and its role in mucosal immunity","volume":"4","author":"Johansen","year":"2011","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0059","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ajo.2014.11.035","article-title":"Long-term result of maintenance treatment with tacrolimus ointment in chronic ocular graft-versus-host disease","volume":"159","author":"Jung","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0060","article-title":"Prolactin inducible protein, but not prolactin, is present in human tears, is involved in tear film quality, and influences evaporative dry eye disease","volume":"9","author":"J\u00fcngert","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0061","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/eye.2011.73","article-title":"Donor-recipient gender difference affects severity of dry eye after hematopoietic stem cell transplantation","volume":"25","author":"Kamoi","year":"2011","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0062","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1038\/srep02455","article-title":"Expression and localization of aging markers in lacrimal gland of chronic graft-versus-host disease","volume":"3","author":"Kawai","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0063","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0161-6420(99)00720-4","article-title":"Ocular findings in allogeneic stem cell transplantation without total body irradiation","volume":"106","author":"El","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0064","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.1167\/iovs.15-17433","article-title":"Corneal epithelial immune dendritic cell alterations in subtypes of dry eye disease: a pilot in vivo confocal microscopic study","volume":"56","author":"Kheirkhah","year":"2015","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0065","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2020-000697","article-title":"Dry eye: why artificial tears are not always the answer","volume":"6","author":"Kim","year":"2021","journal-title":"BMJ Open Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0066","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbmt.2005.11.155","article-title":"Ocular graft vs. host disease experience from MD Anderson Cancer Center: Newly described clinical spectrum and new approach to the management of stage III and IV ocular GVHD","volume":"12","author":"Kim","year":"2006","journal-title":"Biol Blood Marrow Transplantation"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0067","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1016\/j.ophtha.2012.06.052","article-title":"Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study","volume":"119","author":"Kinoshita","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0068","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/ICL.0b013e3182960ff9","article-title":"Using goggles to increase periocular humidity and reduce dry eye symptoms","volume":"39","author":"Korb","year":"2013","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0069","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1479-5876-10-183","article-title":"TGF-\u03b2 - an excellent servant but a bad master","volume":"10","author":"Kubiczkova","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0070","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jtos.2019.10.004","article-title":"Pathological consequences of anti-citrullinated protein antibodies in tear fluid and therapeutic potential of pooled human immune globulin-eye drops in dry eye disease","volume":"18","author":"Kwon","year":"2020","journal-title":"The Ocular Surface"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0071","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJM199205143262006","article-title":"The extracellular actin-scavenger system and actin toxicity","volume":"326","author":"Lee","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0072","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/sj.bmt.1705426","article-title":"Risk factors and characteristics of ocular complications, and efficacy of autologous serum tears after haematopoietic progenitor cell transplantation","volume":"38","author":"Leite","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0073","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1038\/srep05772","article-title":"Tear proteomic analysis of Sj\u00f6gren syndrome patients with dry eye syndrome by two-dimensional-nano-liquid chromatography coupled with tandem mass spectrometry","volume":"4","author":"Li","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0074","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ajo.2022.04.026","article-title":"Metagenomic profiling of the ocular surface microbiome in patients after allogeneic hematopoietic stem cell transplantation","volume":"242","author":"Li","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0075","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jtct.2021.02.008","article-title":"Efficacy and safety of 1% progesterone gel to the forehead for ocular chronic graft-versus-host disease","volume":"27","author":"Luo","year":"2021","journal-title":"Transplantation Cellular Therapy"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0076","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/bmt.2017.9","article-title":"Scleral lenses for severe chronic GvHD-related keratoconjunctivitis sicca: a retrospective study by the SFGM-TC","volume":"52","author":"Magro","year":"2017","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0077","doi-asserted-by":"crossref","first-page":"e2518","DOI":"10.1038\/cddis.2016.410","article-title":"Extracellular histones, cell-free DNA, or nucleosomes: differences in immunostimulation","volume":"7","author":"Marsman","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0078","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1076\/ceyr.19.4.368.5306","article-title":"Identification and immunohistochemical localization of annexin II in rat cornea","volume":"19","author":"Matsuda","year":"1999","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0079","first-page":"1","article-title":"The safety and tolerability of pirfenidone for bronchiolitis obliterans syndrome after hematopoietic cell transplant (STOP-BOS) trial","author":"Matthaiou","year":"2022","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.exer.2013.07.014","article-title":"Antimicrobial compounds in tears","volume":"117","author":"McDermott","year":"2013","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0081","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bbmt.2018.09.003","article-title":"Ruxolitinib as salvage therapy for chronic graft-versus-host disease","volume":"25","author":"Modi","year":"2019","journal-title":"Biol Blood Marrow Transplantation"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0082","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep41939","article-title":"Novel treatment of chronic graft-versus-host disease in mice using the ER stress reducer 4-phenylbutyric acid","volume":"7","author":"Mukai","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0083","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203742","article-title":"Therapeutic potential of tranilast for the treatment of chronic graft-versus-host disease in mice","volume":"13","author":"Mukai","year":"2018","journal-title":"PloS one"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0084","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ajo.2015.04.002","article-title":"Tear osmolarity and ocular surface parameters as diagnostic markers of ocular graft-versus-host disease","volume":"160","author":"Na","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0085","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/bmt.2015.187","article-title":"Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation","volume":"50","author":"Na","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0086","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jtos.2018.04.007","article-title":"Tear inflammatory mediators and protein in eyes of post allogenic hematopoeitic stem cell transplant patients","volume":"16","author":"Nair","year":"2018","journal-title":"Ocul Surf"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0087","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.4103\/ijo.IJO_2016_20","article-title":"Update on ocular graft-versus-host disease","volume":"69","author":"Nair","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0088","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s10792-020-01324-5","article-title":"Management of moderate-to-severe dry eye disease using chitosan-N-acetylcysteine (Lacrimera\u00ae) eye drops: a retrospective case series","volume":"40","author":"Nepp","year":"2020","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0089","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/tvst.9.9.3","article-title":"Tear proteomic predictive biomarker model for ocular graft versus host disease classification","volume":"9","author":"O'Leary","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0090","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/bjo.83.10.1125","article-title":"Dry eye after haematopoietic stem cell transplantation","volume":"83","author":"Ogawa","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0091","first-page":"111","article-title":"A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD","volume":"42","author":"Ogawa","year":"2001","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0092","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1167\/iovs.02-0699","article-title":"Periductal area as the primary site for T-cell activation in lacrimal gland chronic graft-versus-host disease","volume":"44","author":"Ogawa","year":"2003","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0093","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.2353\/ajpath.2009.090318","article-title":"Epithelial mesenchymal transition in human ocular chronic graft-versus-host disease","volume":"175","author":"Ogawa","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0094","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/bmt.2009.173","article-title":"Topical tranilast for treatment of the early stage of mild dry eye associated with chronic GVHD","volume":"45","author":"Ogawa","year":"2010","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep03419","article-title":"International chronic ocular graft-vs-host-disease (GVHD) consensus group: proposed diagnostic criteria for chronic GVHD (Part I)","volume":"3","author":"Ogawa","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0096","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep42195","article-title":"Heavy chain-hyaluronan\/pentraxin 3 from amniotic membrane suppresses inflammation and scarring in murine lacrimal gland and conjunctiva of chronic graft-versus-host disease","volume":"7","author":"Ogawa","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0097","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1182\/bloodadvances.2018028431","article-title":"Ocular instillation of vitamin A\u2013coupled liposomes containing HSP47 siRNA ameliorates dry eye syndrome in chronic GVHD","volume":"3","author":"Ohigashi","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0098","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.ICL.0000060998.20142.8D","article-title":"Increase in tear film lipid layer thickness following treatment with warm compresses in patients with meibomian gland dysfunction","volume":"29","author":"Olson","year":"2003","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0099","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009327.pub3","article-title":"Autologous serum eye drops for dry eye","author":"Pan","year":"2017","journal-title":"Cochrane Database Systematic Rev"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0100","first-page":"169","article-title":"Successful treatment of dry mouth and dry eye symptoms in Sj\u00f6gren's syndrome patients with oral pilocarpine: a randomized, placebo-controlled, dose-adjustment study","volume":"10","author":"Papas","year":"2004","journal-title":"JCR: J Clin Rheumatol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0101","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/s41409-018-0090-z","article-title":"Ocular findings and ocular graft-versus-host disease after allogeneic stem cell transplantation without total body irradiation","volume":"53","author":"Pathak","year":"2018","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0102","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ajo.2021.02.022","article-title":"Incidence, risk factors and complications of ocular graft-versus-host disease following hematopoietic stem cell transplantation","volume":"227","author":"Pellegrini","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0103","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(19)30256-X","article-title":"Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","volume":"7","author":"Penack","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0104","doi-asserted-by":"crossref","first-page":"29629","DOI":"10.1038\/srep29629","article-title":"Proteomics analysis of human tears from aqueous-deficient and evaporative dry eye patients","volume":"6","author":"Perumal","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0105","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/s41409-021-01254-5","article-title":"Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study","volume":"56","author":"Pietraszkiewicz","year":"2021","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0106","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1097\/ICL.0000000000000445","article-title":"Single-center retrospective study on meibomian gland loss in patients with ocular chronic graft-versus-host disease","volume":"44","author":"Que","year":"2018","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0107","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/aos.12047","article-title":"Impact of ocular graft-versus-host disease on visual quality of life in patients after allogeneic stem cell transplantation: questionnaire study","volume":"92","author":"Riemens","year":"2014","journal-title":"Acta Ophthalmologica"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0108","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/sj.bmt.1704453","article-title":"Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease","volume":"33","author":"Robinson","year":"2004","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0109","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ncb1909","article-title":"Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion","volume":"11","author":"Rodier","year":"2009","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0110","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1083\/jcb.139.7.1835","article-title":"Periplakin, a novel component of cornified envelopes and desmosomes that belongs to the plakin family and forms complexes with envoplakin","volume":"139","author":"Ruhrberg","year":"1997","journal-title":"J Cell Biol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0111","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3341\/kjo.2012.26.4.241","article-title":"Therapeutic effect of 0.03% tacrolimus ointment for ocular graft versus host disease and vernal keratoconjunctivitis","volume":"26","author":"Ryu","year":"2012","journal-title":"Korean J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0112","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00417-016-3312-3","article-title":"Prevalence of ocular hypertension and glaucoma in patients with chronic ocular graft-versus-host disease","volume":"254","author":"Saboo","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0113","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/bmt.2011.205","article-title":"Punctal occlusion is safe and efficient for the treatment of keratoconjunctivitis sicca in patients with ocular GvHD","volume":"47","author":"Sabti","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0114","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/BF02982052","article-title":"Ocular manifestation of acute graft-versus-host disease after allogeneic peripheral blood stem cell transplantation","volume":"75","author":"Saito","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0115","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.3390\/ijms22073745","article-title":"Positive effects of oral antibiotic administration in murine chronic graft-versus-host disease","volume":"22","author":"Sato","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0116","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/s41409-018-0204-7","article-title":"EBMT\u2212 NIH\u2212 CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment","volume":"53","author":"Schoemans","year":"2018","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0117","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nm.3517","article-title":"Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage","volume":"20","author":"Schwab","year":"2014","journal-title":"Nature Med"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0118","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2015.06.023","article-title":"Out-of-sequence signal 3 paralyzes primary CD4+ T-cell-dependent immunity","volume":"43","author":"Sckisel","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0119","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1167\/iovs.19-27843","article-title":"Graft versus host disease-associated dry eye: role of ocular surface mucins and the effect of rebamipide, a mucin secretagogue","volume":"60","author":"Shamloo","year":"2019","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1167\/iovs.62.13.10","article-title":"Local renin-angiotensin system activation and myofibroblast formation in graft versus host disease\u2013associated conjunctival fibrosis","volume":"62","author":"Shamloo","year":"2021","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0121","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/ICO.0000000000000340","article-title":"Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation","volume":"34","author":"Shikari","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0122","doi-asserted-by":"crossref","first-page":"DES7","DOI":"10.1167\/iovs.17-23475","article-title":"Definition and diagnostic criteria of dry eye disease: historical overview and future directions","volume":"59","author":"Shimazaki","year":"2018","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0123","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jtos.2019.02.001","article-title":"Commensal microflora in human conjunctiva; characteristics of microflora in the patients with chronic ocular graft-versus-host disease","volume":"17","author":"Shimizu","year":"2019","journal-title":"Ocul Surf"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0124","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jtos.2020.07.018","article-title":"Efficacy and retention of silicone punctal plugs for treatment of dry eye in patients with and without ocular graft-versus-host-disease","volume":"18","author":"Singh","year":"2020","journal-title":"Ocul Surf"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jtos.2022.07.001","article-title":"Prevalence of neurotrophic keratopathy in patients with chronic ocular graft-versus-host disease","volume":"26","author":"Singh","year":"2022","journal-title":"Ocular Surface"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0126","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/ICO.0000000000002526","article-title":"Prevalence and risk factors associated with corneal perforation in chronic ocular graft-versus-host-disease","volume":"40","author":"Sinha","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0127","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1600-065X.2007.00537.x","article-title":"The role of the integrin LFA-1 in T-lymphocyte migration","volume":"218","author":"Smith","year":"2007","journal-title":"Immunol Revi"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0128","doi-asserted-by":"crossref","first-page":"8253","DOI":"10.1167\/iovs.12-10430","article-title":"Ocular surface extracellular DNA and nuclease activity imbalance: a new paradigm for inflammation in dry eye disease","volume":"53","author":"Sonawane","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0129","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100176","article-title":"A randomized trial of topical fibrinogen-depleted human platelet lysate treatment of dry eye secondary to chronic graft-versus-host disease","volume":"2","author":"Sugar","year":"2022","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0130","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.ophtha.2009.04.054","article-title":"Ocular findings after allogeneic hematopoietic stem cell transplantation","volume":"116","author":"Tabbara","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0131","first-page":"121","article-title":"Detection of systemic immunosuppressants in autologous serum eye drops (ASED) in patients with severe chronic ocular graft versus host disease. Graefe's Archive for","volume":"259","author":"Tahmaz","year":"2021","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0132","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/jop.2011.0142","article-title":"Rebamipide increases the mucin-like glycoprotein production in corneal epithelial cells","volume":"28","author":"Takeji","year":"2012","journal-title":"J Ocular Pharmacol Therapeutics"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep06680","article-title":"Grading criteria for chronic ocular graft-versus-host disease: Comparing the NIH eye score, Japanese dry eye score and DEWS 2007 score","volume":"4","author":"Tatematsu","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0134","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/cncr.10773","article-title":"High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases","volume":"95","author":"Tauchmanov\u00e0","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0135","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2991\/chi.d.200115.001","article-title":"Current status and future directions in graft-versus-host disease prevention following allogeneic blood and marrow transplantation in adults","volume":"2","author":"Tegla","year":"2020","journal-title":"Clin Hematol Int"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0136","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/sj.eye.6700566","article-title":"Tears in health and disease","volume":"17","author":"Tiffany","year":"2003","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0137","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/cmi.2010.67","article-title":"The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases","volume":"8","author":"Tlaskalov\u00e1-Hogenov\u00e1","year":"2011","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0138","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/bjophthalmol-2011-300514","article-title":"Comparison of stem cell sources in the severity of dry eye after allogeneic haematopoietic stem cell transplantation","volume":"96","author":"Uchino","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0139","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1089\/jop.2011.0147","article-title":"Rebamipide increases mucin-like substance contents and periodic acid Schiff reagent-positive cells density in normal rabbits","volume":"28","author":"Urashima","year":"2012","journal-title":"J Ocular Pharmacol Therapeutics"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0140","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3389\/fphys.2014.00439","article-title":"The impact of age-related dysregulation of the angiotensin system on mitochondrial redox balance","volume":"5","author":"Vajapey","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0141","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/308976","article-title":"Annexin A2: its molecular regulation and cellular expression in cancer development","author":"Wang","year":"2014","journal-title":"Dis Markers"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0142","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1136\/bjophthalmol-2014-306438","article-title":"Risk factors for the development of ocular graft-versus-host disease (GVHD) dry eye syndrome in patients with chronic GVHD","volume":"99","author":"Wang","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0143","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.bmt.1705900","article-title":"Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease","volume":"41","author":"Wang","year":"2008","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0144","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/bmt.2009.312","article-title":"Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye","volume":"45","author":"Wang","year":"2010","journal-title":"Bone Marrow Transplantation"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0145","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/ICO.0000000000002384","article-title":"Long-term outcomes of punctal cauterization in the management of ocular surface diseases","volume":"40","author":"Wang","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0146","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/bmt.2009.346","article-title":"Differential chemokine expression in chronic GVHD of the conjunctiva","volume":"45","author":"Westekemper","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0147","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.bbmt.2010.06.015","article-title":"Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD","volume":"16","author":"Wolff","year":"2010","journal-title":"Biol Blood Marrow Transplantation"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0148","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jtos.2017.05.001","article-title":"TFOS DEWS II diagnostic methodology report","volume":"15","author":"Wolffsohn","year":"2017","journal-title":"Ocular Surface"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0149","doi-asserted-by":"crossref","first-page":"488","DOI":"10.4049\/jimmunol.1300657","article-title":"Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells","volume":"191","author":"Wu","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0150","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/bmt.2012.50","article-title":"Surgical management of lacrimal punctal cauterization in chronic GVHD-related dry eye with recurrent punctal plug extrusion","volume":"47","author":"Yaguchi","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0151","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1167\/iovs.12-9891","article-title":"Presence and physiologic function of the renin\u2013angiotensin system in mouse lacrimal gland","volume":"53","author":"Yaguchi","year":"2012","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0152","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1097\/ICO.0000000000000586","article-title":"Tissue renin\u2013angiotensin system in lacrimal gland fibrosis in a murine model of chronic graft-versus-host disease","volume":"34","author":"Yaguchi","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0153","doi-asserted-by":"crossref","first-page":"S215","DOI":"10.1097\/ICL.0000000000000455","article-title":"Long-term topical diquafosol tetrasodium treatment of dry eye disease caused by chronic graft-versus-host disease: a retrospective study","volume":"44","author":"Yamane","year":"2018","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0154","doi-asserted-by":"crossref","first-page":"10778","DOI":"10.1096\/fj.201900218R","article-title":"Senescence-associated secretory phenotype promotes chronic ocular graft-vs-host disease in mice and humans","volume":"34","author":"Yamane","year":"2020","journal-title":"Faseb j"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0155","article-title":"Eyelid blood vessel and meibomian gland changes in a sclerodermatous chronic GVHD mouse model","author":"Yang","year":"2021","journal-title":"Ocular Surface"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0156","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajo.2018.03.024","article-title":"Reduced efficacy of low-dose topical steroids in dry eye disease associated with graft-versus-host disease","volume":"190","author":"Yin","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0157","first-page":"180","article-title":"Tear lipocalin is the major endonuclease in tears","volume":"14","author":"Yusifov","year":"2008","journal-title":"Mol Vis"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0158","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease\u2014biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"New Engl J Med"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0159","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1016\/j.jprot.2012.04.053","article-title":"In-depth analysis of the human tear proteome","volume":"75","author":"Zhou","year":"2012","journal-title":"J Proteomics"},{"key":"10.1016\/j.survophthal.2023.02.006_bib0160","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jtos.2020.07.007","article-title":"Assessing the ocular surface microbiome in severe ocular surface diseases","volume":"18","author":"Zilliox","year":"2020","journal-title":"Ocul Surf"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625723000425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625723000425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:54:29Z","timestamp":1758542069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625723000425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":160,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0039625723000425"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2023.02.006","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular graft-versus-host disease (oGVHD): From A to Z","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2023.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}